Type 2 diabetes is associated with reduced cardiorespiratory fitness compared to peers without the condition, driven by insulin resistance and mitochondrial, vascular, and cardiac dysfunction.
This review outlines the complex, interrelated mechanisms—such as insulin resistance and mitochondrial, vascular, and cardiac dysfunction—that contribute to reduced cardiorespiratory fitness in patients with type 2 diabetes.
Type 2 diabetes (T2D) has been rising in prevalence in the United States and worldwide over the past few decades and contributes to significant morbidity and premature mortality, primarily due to cardiovascular disease (CVD). Cardiorespiratory fitness (CRF) is a modifiable cardiovascular (CV) risk factor in the general population and in people with T2D. Young people and adults with T2D have reduced CRF when compared with their peers without T2D who are similarly active and of similar body mass index. Furthermore, the impairment in CRF conferred by T2D is greater in women than in men. Various factors may contribute to this abnormality in people with T2D, including insulin resistance and mitochondrial, vascular, and cardiac dysfunction. As proof of concept that understanding the mediators of impaired CRF in T2D can inform intervention, we previously demonstrated that an insulin sensitizer improved CRF in adults with T2D. This review focuses on how contributing factors influence CRF and why they may be compromised in T2D. Functional exercise capacity is a measure of interrelated systems biology; as such, the contribution of derangement in each of these factors to T2D-mediated impairment in CRF is complex and varied. Therefore, successful approaches to improve CRF in T2D should be multifaceted and individually designed. The current status of this research and future directions are outlined.
Abushamat et al. (Sun,) conducted a review in Type 2 diabetes. Type 2 diabetes vs. Peers without type 2 diabetes was evaluated on Cardiorespiratory fitness. Type 2 diabetes is associated with reduced cardiorespiratory fitness compared to peers without the condition, driven by insulin resistance and mitochondrial, vascular, and cardiac dysfunction.